Verastem Oncology (VSTM) Announces Proposed Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Verastem (VSTM) PT Lowered to $7 at B.Riley
July 24, 2024 7:02 AM EDTB.Riley analyst Kalpit Patel lowered the price target on Verastem (NASDAQ: VSTM) to $7.00 (from $21.00) while maintaining a Buy rating.
The analyst comments "Verastem (VSTMBuy, $7 PT) announced a proposed public offering after market close on 7/23/24. Our enthusiasm for the drugs potential... More
